97 related articles for article (PubMed ID: 137262)
1. The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity.
Schwartz A; Askenase PW; Gershon RK
J Immunol; 1977 Jan; 118(1):159-65. PubMed ID: 137262
[TBL] [Abstract][Full Text] [Related]
2. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine.
Ptak W; Geba GP; Askenase PW
J Immunol; 1991 Jun; 146(11):3929-36. PubMed ID: 2033262
[TBL] [Abstract][Full Text] [Related]
3. Regulation of delayed-type hypersensitivity-like responses in the mouse lung, determined with histological procedures: serotonin, T-cell suppressor-inducer factor and high antigen dose tolerance regulate the magnitude of T-cell dependent inflammatory reactions.
Garssen J; Nijkamp FP; Wagenaar SS; Zwart A; Askenase PW; Van Loveren H
Immunology; 1989 Sep; 68(1):51-8. PubMed ID: 2807371
[TBL] [Abstract][Full Text] [Related]
4. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
Ptak W; Herzog WR; Askenase PW
J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
[TBL] [Abstract][Full Text] [Related]
5. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice.
Askenase PW; Van Loveren H; Kraeuter-Kops S; Ron Y; Meade R; Theoharides TC; Nordlund JJ; Scovern H; Gerhson MD; Ptak W
J Immunol; 1983 Dec; 131(6):2687-94. PubMed ID: 6605986
[TBL] [Abstract][Full Text] [Related]
6. A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells.
Ameisen JC; Meade R; Askenase PW
J Immunol; 1989 May; 142(9):3171-9. PubMed ID: 2785136
[TBL] [Abstract][Full Text] [Related]
7. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity.
Van Loveren H; Kato K; Meade R; Green DR; Horowitz M; Ptak W; Askenase PW
J Immunol; 1984 Nov; 133(5):2402-11. PubMed ID: 6332850
[TBL] [Abstract][Full Text] [Related]
8. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.
Van Loveren H; Askenase PW
J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849
[TBL] [Abstract][Full Text] [Related]
9. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
10. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.
Van Loveren H; Den Otter W; Meade R; Terheggen PM; Askenase PW
J Immunol; 1985 Feb; 134(2):1292-9. PubMed ID: 3871209
[TBL] [Abstract][Full Text] [Related]
11. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
Ptak W; Bereta M; Ptak M; Askenase PW
J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404
[TBL] [Abstract][Full Text] [Related]
12. An antigen-specific DTH-initiating cell clone. Functional, phenotypical, and partial molecular characterization.
Herzog WR; Millet I; Ferreri NR; Ramabhadran R; Schreurs J; Askenase PW
J Immunol; 1990 May; 144(10):3667-76. PubMed ID: 1970589
[TBL] [Abstract][Full Text] [Related]
13. Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions.
Gershon RK; Askenase PW; Gershon MD
J Exp Med; 1975 Sep; 142(3):732-47. PubMed ID: 1165473
[TBL] [Abstract][Full Text] [Related]
14. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
Herzog WR; Ferreri NR; Ptak W; Askenase PW
J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
[TBL] [Abstract][Full Text] [Related]
15. Nude mice produce a T cell-derived antigen-binding factor that mediates the early component of delayed-type hypersensitivity.
Herzog WR; Meade R; Pettinicchi A; Ptak W; Askenase PW
J Immunol; 1989 Mar; 142(6):1803-12. PubMed ID: 2466077
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta 1 inhibits murine immediate and delayed type hypersensitivity.
Meade R; Askenase PW; Geba GP; Neddermann K; Jacoby RO; Pasternak RD
J Immunol; 1992 Jul; 149(2):521-8. PubMed ID: 1624798
[TBL] [Abstract][Full Text] [Related]
17. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.
Fong TA; Mosmann TR
J Immunol; 1989 Nov; 143(9):2887-93. PubMed ID: 2530282
[TBL] [Abstract][Full Text] [Related]
18. Delayed-type hypersensitivity to sheep red blood cells in selected lines of mice with high or low antibody responses.
Lagrange PH; Michel JC; Hurtrel B; Thickstun PM
Ann Immunol (Paris); 1980; 131C(3):257-77. PubMed ID: 7406440
[TBL] [Abstract][Full Text] [Related]
19. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
Matsushima GK; Stohlman SA
J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
[TBL] [Abstract][Full Text] [Related]
20. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
